Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
0 this month

Showing 8241–8260 of 17,529 recalls

August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Valsartan Tablets USP

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine and Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 17, 2018· Torrent Pharma Inc.

Recalled Item: Amlodipine

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
August 15, 2018· Hetero Labs Limited Unit V

Recalled Item: Montelukast Sodium Tablets 10 mg

The Issue: Labeling: Label Mix-Up - One lot labeled Montelukast

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
August 15, 2018· Preferred Pharmaceuticals, Inc

Recalled Item: Valsartan Tablets USP 320 mg

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 14, 2018· United Therapeutics Corp.

Recalled Item: Tyvaso Inhalation System Patient a) Starter Kit with TYVASO (treprostinil)

The Issue: Defective Delivery System: Water ingress through the lower

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskTerminated
Refund
August 14, 2018· Mckesson Corporation

Recalled Item: Megestrol Acetate Oral Suspension

The Issue: Supterpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
August 14, 2018· AVKARE Inc.

Recalled Item: Valsartan Tablets

The Issue: CGMP Deviations: Carcinogen impurity detected in API used

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund